Eli Lilly projects 32% revenue growth for 2025, fueled by incretin expansion and new launches
Q4 2024 Management View CEO David Ricks highlighted a 45% revenue growth in Q4, with significant contributions from Mounjaro and Zepbound. He emphasized ongoing expansion in manufacturing to meet ...
Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...
Deccan Chronicle28d
Lilly to establish new global capability centre in Hyderabad
Hyderabad: Eli Lilly and Company, a multinational pharmaceutical company, announced plans to establish a new global capability centre in Hyderabad on Thursday. The new centre will be named *Lilly ...
The Business Journals25d
Lilly to pay $2.5B for Boston biotech's lead cancer drug
Eli Lilly and Co., which cemented its place in Boston last year with the opening of a new research and development center, is now buying a cancer program from a Boston biotech. Eli Lilly and Co ...